Dr. Jung is a recipient of the Thomas J. Layden Endowed Professorship in Digestive and Liver Diseases.
Her clinical experience includes the diagnosis and management of patients who are at an increased risk for GI cancers, including polyposis and Lynch syndromes.
Dr. Jung is establishing a clinical and tissue registry to aid research in high risk GI cancer conditions.
Dr. Jung’s laboratory studies potential biomarkers to predict treatment outcomes, in addition to the mechanisms of colon cancer progression and metastasis.
More articles on gastroenterology:
Dr. Craig Christensen receives 2018 Physician Recognition Award
Inconvenient no more — Partnership makes GI guidelines easier to use
Dr. Akash Ajmera on the future of gastroenterology, encouraging CRC screenings & more
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.